We are monitoring the impact of COVID-19 & Recession alarm on MEA Companion Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Companion Diagnostics Market Research Report – Segmented By Indication, By Technology & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 593
Pages: 145

MEA Companion Diagnostics Market Size (2022 to 2027)

As per our report, the size of the Companion Diagnostics Market in the Middle East & Africa was worth USD 0.13 billion in 2022 and is estimated to be growing at a CAGR of 21.11% to reach USD 0.35 billion by 2027.

Companion diagnostic has the potential to modify the drug development process, and the commercialization of the drug diagnoses will make drugs with better therapeutic efficiency in a faster and cost-effective way. In addition, companion diagnostics has been highly advantageous for identifying patients with precise biomarkers with predictive responses.

Innovative technologies such as next-generation sequencing (NGS), growing acceptance of companion diagnostic kits/tests by the pharmaceutical industry, and boost from controlling bodies are anticipated to enhance the market. NGS-based companion diagnostics is one of the significant factors that are expected to drive the companion diagnostics market in the Middle East and African region due to its ability to identify multiple genes at a single time.

Regulatory uncertainty and cost allied with developing drugs are expected to hamper the growth of the MEA companion diagnostics market during the forecast period.

This research report on the Middle East and Africa Companion Diagnostics Market has been segmented and sub-segmented into the following categories:

By Indications:

  • Oncology
    • Colorectal Cancer
    • Lung Cancer
    • Breast Cancer
    • Gastric Cancer
    • Melanoma
  • Inflammation and Autoimmune Diseases
  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Virology Diseases

By Technology:

  • Immunohistochemistry
  • Molecular Diagnostics
    • In-Situ Hybridization
    • Real-Time PCR
    • Gene Sequencing

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Regionally, the African companion diagnostics market is expected to grow at the highest CAGR in this region during the forecast period. On the other hand, the Middle East companion diagnostics market is estimated to have a sluggish growth rate during the forecast period. This region's growth is attributed to factors such as the growing need for improved personalized patient treatment, which has contributed to healthcare providers. Also, growing support from government reimbursement policies for bringing out better treatment in ordinary people accelerates the companion diagnostics market growth over the analysis period.

The South African market is expected to grow at a notable rate during the forecast period. The growth of Africa has contributed towards the companion diagnostics market due to factors such as increasing acceptance for diagnostics tests/kits by the pharmaceutical industry, reimbursement policies made by the government are likely to anticipate the market of this region. However, the cost related to this diagnostics market is so expensive, and the lack of lab technicians and lack of infrastructure in the diagnostics centers may hinder the companion diagnostics market growth over the forecast period.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the MEA Companion Diagnostics Market profiled in this report are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc., and Thermo Fisher Scientific Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Companion Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Oncology Market By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa Inflammation and Autoimmune Diseases Market By Region, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa Cardiovascular Diseases Market By Region, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa Central Nervous System Disorders Market By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa Virology Diseases Market By Region, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Immuno Histochemistry Market By Region, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Molecular Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  12. Middle East & Africa Colorectal Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  13. Middle East & Africa Breast Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  14. Middle East & Africa Lung Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  15. Middle East & Africa Gastric Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  16. Middle East & Africa Melanoma Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  17. Middle East & Africa Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  18. Middle East & Africa In-Situ Hybridization Market By Region, From 2022 - 2027 (USD Billion)
  19. Middle East & Africa Real Time PCR Market By Region, From 2022 - 2027 (USD Billion)
  20. Middle East & Africa Gene Sequencing Market By Region, From 2022 - 2027 (USD Billion)
  21. Middle East Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  22. Middle East Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  23. Middle East Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  24. Middle East Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  25. Africa Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  26. Africa Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  27. Africa Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  28. Africa Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample